Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
118actual
Sites
21
Countries
Belgium, Czechia, France +5
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2011-09-21 | actual | When the study began enrolling |
| Primary completion | May 2014 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-06-30 | estimated | The whole study's end, after follow-up |
| First posted | 2011-06-30 | estimated | When this record first appeared on the registry |
| Results posted | 2020-01-06 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Heart Failure
- Congestive Heart Failure
Interventions
- Device: Implant of investigational device system
- Procedure: Titration during the randomization phase
- Procedure: Titration after the randomization phase
- Diagnostic test: Blood Draw
Primary outcomes
what the primary-completion date above is the date OFChange in Left Ventricular End-systolic Dimension (LVESD)
measured LVESD at Baseline and at 6-months post Baseline
Percentage of Surviving Participants
measured 18-months
Publications
- PMID 25176942 — reports results
- PMID 28663046 — reports results
- PMID 24846173 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed